Multiple skin cancers associated with hydroxyurea therapy

被引：31

作者：

Best, PJM

Petitt, RM

机构：

[1] Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA

[2] Mayo Clin & Mayo Fdn, Div Hematol & Internal Med, Rochester, MN 55905 USA

来源：

MAYO CLINIC PROCEEDINGS | 1998年 / 73卷 / 10期

关键词：

D O I：

10.4065/73.10.961

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The association of multiple cutaneous cancers and longterm use of hydroxyurea is now being recognized. In this article, we describe the development of multiple skin tumors in two patients who were receiving hydroxyurea therapy. These cases illustrate the late onset of subsequent skin cancers despite discontinuation of therapy. As hydroxyurea continues to leave a prominent role in the treatment of myeloproliferative diseases, clinicians must he aware of the increased risk of multiple skin cancers and use-preventive and skin cancer screening practices in patients with these diseases.

引用

页码：961 / 963

页数：3

共 12 条

[1] MULTIPLE SQUAMOUS-CELL CARCINOMAS OF THE SCALP AND CHRONIC MYELOID-LEUKEMIA [J].

ANGELIBESSON, C ;

KOEPPEL, MC ;

JACQUET, P ;

ANDRAC, L ;

SAYAG, J .

DERMATOLOGY, 1995, 191 (04) :321-322

[2] Hydroxyurea-induced leg ulceration in 14 patients [J].

Best, PJ ;

Daoud, MS ;

Pittelkow, MR ;

Petitt, RM .

ANNALS OF INTERNAL MEDICINE, 1998, 128 (01) :29-32

[3] HYDROXYUREA THERAPY [J].

BOYD, AS .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 25 (03) :518-524

[4] Cutaneous carcinoma during long-term hydroxyurea therapy: A report of 5 cases [J].

CallotMellot, C ;

Bodemer, C ;

Chosidow, O ;

Frances, C ;

Azgui, Z ;

Varet, B ;

deProst, Y .

ARCHIVES OF DERMATOLOGY, 1996, 132 (11) :1395-1397

[5] EFFECT OF HYDROXYUREA ON THE FREQUENCY OF PAINFUL CRISES IN SICKLE-CELL-ANEMIA [J].

CHARACHE, S ;

TERRIN, ML ;

MOORE, RD ;

DOVER, GJ ;

BARTON, FB ;

ECKERT, SV ;

MCMAHON, RP ;

BONDS, DR ;

ORRINGER, E ;

JONES, S ;

STRAYHORN, D ;

ROSSE, W ;

PHILLIPS, G ;

PEACE, D ;

JOHNSONTELFAIR, A ;

MILNER, P ;

KUTLAR, A ;

TRACY, A ;

BALLAS, SK ;

ALLEN, GE ;

MOSHANG, J ;

SCOTT, B ;

STEINBERG, M ;

ANDERSON, A ;

SABAHI, V ;

PEGELOW, C ;

TEMPLE, D ;

CASE, E ;

HARRELL, R ;

CHILDERIE, S ;

EMBURY, S ;

SCHMIDT, B ;

DAVIES, D ;

KOSHY, M ;

TALISCHYZAHED, N ;

DORN, L ;

PENDARVIS, G ;

MCGEE, M ;

TELFER, M ;

DAVIS, A ;

CASTRO, O ;

FINKE, H ;

PERLIN, E ;

SITEMAN, J ;

GASCON, P ;

DIPAOLO, P ;

GARGIULO, S ;

ECKMAN, J ;

BAILEY, JH ;

PLATT, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1317-1322

[6] INHIBITION OF DNA-REPAIR IN ULTRAVIOLET-IRRADIATED HUMAN-CELLS BY HYDROXYUREA [J].

FRANCIS, AA ;

BLEVINS, RD ;

CARRIER, WL ;

SMITH, DP ;

REGAN, JD .

BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 563 (02) :385-392

[7] ENHANCEMENT OF METHYLNITROSOUREA SKIN CARCINOGENESIS BY INHIBITING CELL-PROLIFERATION WITH HYDROXYUREA OR SKIN EXTRACTS [J].

IVERSEN, OH .

CARCINOGENESIS, 1982, 3 (08) :881-889

[8] SKIN CHANGES SECONDARY TO HYDROXYUREA THERAPY [J].

KENNEDY, BJ ;

SMITH, LR ;

GOLTZ, RW .

ARCHIVES OF DERMATOLOGY, 1975, 111 (02) :183-187

[9]

KINSELLA TJ, 1992, SEMIN ONCOL, V19, P41

[10]

KLEM EB, 1978, J INVEST DERMATOL, V70, P27, DOI 10.1111/1523-1747.ep12543421

← 1 2 →